DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Pace A, Mandoj C, Antenucci A. et al.
A predictive value of von Willebrand factor for early response to Bevacizumab therapy in recurrent glioma.
J Neurooncol 2018;
138 (03) 527-535
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.